PERKINS ADELENE Q (Chief Executive Officer) received a stock award from INFINITY PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/13/2020ACC: 0000899243-20-001080
DirectorOfficer· Chief Executive Officer
Since Oct 2018
+761.38K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
761.38K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+155.13K
Price / share
—
Trade value
—
% of position
24.3%
1/10/2020
638.06K→793.19K
Total
Net shares
+155.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2020 | A · Award | +155.13K | — | — | 24.3% | 638.06K | 793.19K |
| Total | +155.13K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
606.25K shares
Shares
+606.25K
Strike price
1.25
Held after
606.25K
Exercisable
—
1/10/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock606.25K shares | 1/10/2020 | A · Award | +606.25K | 1.25 | — | 606.25K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned16.45K
Total
16.45K indirect16.45K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.45K | Indirect |
| Total | 16.45K | 16.45K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported